Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cachexia × Fluoxetine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Anxiety Disorders 2 Weight Loss 1 Recurrence 1 Lung Neoplasms 1 Glioma 1 Fatigue 1 Depression 1 Colorectal Adenocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Cachexia 1 Brain Neoplasms 1 Advanced Cancer 1 Adenocarcinoma of Lung 1

Interventions

Megestrol Acetate 7 Exercise 5 Standard of Care 4 Olanzapine 3 Blood Specimen Collection 3 dermcidin 2 Resistance Training 2 Physical Therapy Modalities 2 Nutrition Assessment 2 Mirtazapine 2 Ibuprofen 2 Enteral Nutrition 2 Diet Therapy 2 Cyproheptadine 2 testosterone enanthate 1 telotristat ethyl 1 remune 1 olanzapine-fluoxetine combination 1 nabiximols 1 nabilone 1 irinotecan sucrosofate 1 fucoidan 1 bermekimab 1 anamorelin 1 Vitamin D 1 Ultrasonography 1 Retrospective Studies 1 Radiotherapy 1 Powders 1 Omacor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00489593 2015-01-08

Olanzapine in Patients With Advanced Cancer and Weight Loss

M.D. Anderson Cancer Center

Phase 1 Completed

Cachexia, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡